Optibiotix Health Plc
Company Profile
Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description
OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company Summary
Investor Access
26
Jul
Event information
2023 Annual General Meeting
(please check the link for more information: https://www.londonstockexchange.com/news-article/OPTI/final-results/16017101)
Venue
Walbrook PR Ltd, 75 King William Street, London, EC3V 9HD
Time
Wednesday, 26 July 2023 at11.00 am
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | May |
| Interim Results* | September |
| AGM* | July |
* Months based on previous announcements of this kind
